
| Revenue | Less than $1 million See Exact Annual Revenue |
|---|---|
| Employees | N/AExact Company Size |
| Primary Industry | 325411 Medicinal & Botanical Manufacturing |
| Additional NAICS Codes | 325413 In-Vitro Diagnostic Substance Manufacturing 5417 Scientific Research & Development Services |
| Address | 37 Birch Street Milford, MA 01757 |
| Seracare Life Sciences | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | Less than $1 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Seracare Life Sciences P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| SERASEQ Chemical reagents for non-medical purposes * and non-forensic purposes, namely, synthetic and natural DNA and RNA formulations; * diagnostic chemicals, reagents, or preparations for scientific [, research, clinical or medical laboratory use ] * use, namely, for use in assisting the characterization and monitoring of genomic sequencing assays; diagnostic chemicals, reagents, or preparations for research use, namely, for use in assisting the characterization and monitoring of genomic sequencing assays; diagnostic chemicals, reagents, or preparations for clinical use, namely, for use in assisting the characterization and monitoring of genomic sequencing assays; diagnostic chemicals, reagents, or preparations for medical laboratory use, namely, for use in assisting the characterization and monitoring of genomic sequencing assays * | 12/28/2015 |
| BACTRACE Specific antibodies to bacteria for use in in vitro diagnostic and biological research and companion reagents for use in in vitro diagnostic and biological research; unmodified bacteria for use as controls in scientific research | 08/06/2013 |
| SERASURE Growth media for general cell culture of mammalian, insect, plant and stem cells | 07/07/2011 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| XYMOGEN | Orlando, FL | 100 |
| AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
| NUTRITION FORMULATORS | Miramar, FL | 36 |
| RTPR | Cabot, AR | 33 |
| INTEGRATED BOTANICS | Fort Worth, TX | 29 |
| COSMAX NBT USA | Garland, TX | 29 |
| CJB INDUSTRIES | Valdosta, GA | 28 |
| ALTERNATIVE LABORATORIES | Naples, FL | 28 |
| S&B PHARMA | Azusa, CA | 28 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| SUMITOMO PHARMA AMERICA | Marlborough, MA | 100 |
| OXFORD BIOMEDICA SOLUTIONS | Bedford, MA | 7 |
| DELIX THERAPEUTICS | Concord, MA | 4 |
| SINOVENT PHARMACEUTICALS | Concord, MA | 2 |
| IMV | Sherborn, MA | 2 |
| ALLORION THERAPEUTICS | Natick, MA | 2 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| CONTINUING CARE MANAGEMENT | Milford, MA | 100 |
| LP INNOVATIONS | Milford, MA | 4 |
| DAVID M WOLF DDS PC | Milford, MA | 1 |
| KIRKEGAARD & PERRY LABS | Milford, MA | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |